Propanc Biopharma, Inc. (PPCB) Financials

$0.61

$-0.02 (-3.17%)

As on 18-Sep-2026 16:24EDT

Market cap

$1 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

0

P/B Ratio

0.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Operating Revenue	0.03	--	--	--	--	--
Cost of Revenue	0.02	--	0.02	0.02	0.01	0.03
Gross Profit	0.00	--	-0.02	-0.02	-0.01	-0.03
Operating Expenses	18.37	57.28	1.51	1.76	1.99	1.81
Operating Profit (EBIT)	-18.37	-57.28	-1.54	-1.78	-1.99	-1.81
Other Income	--	--	--	--	--	--
Profit before Tax	-18.36	-58.92	-1.95	-2.79	-2.71	-2.14
Provision for Tax	--	--	-0.13	-0.13	-0.05	-0.11
Profit after Tax (Net Income)	-18.36	-58.92	-1.82	-2.66	-2.66	-2.03
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-3.13	-3.36	-2.42

Liabilities ($ Mln)	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Shareholder's Funds	9.83	13.91	-3.78	-3.12	-3.02	-3.07
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.03	0.15	0.06	0.02	0.04	--
Current Liabilities	3.48	5.58	3.79	3.16	3.06	3.08
Total Liabilities	17.81	19.63	0.07	0.06	0.08	0.01

Assets ($ Mln)	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Non-Current Assets	6.11	11.28	0.05	0.04	0.07	0.01
Current Assets	8.22	8.35	0.03	0.02	0.02	0.01
Total Assets	17.81	19.63	0.07	0.06	0.08	0.01
Total Debt*	1.57	1.73	0.95	0.55	1.04	0.68
Net Current Assets	4.75	2.77	-3.77	-3.14	-3.05	-3.07

Cashflow ($ Mln)	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Cash From Operating Activities	--	-0.41	-0.94	-1.11	-1.44	-1.15
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	0.49	0.94	1.11	1.49	1.06
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Adjusted EPS ($)	-13.62	-5.07	-227.63	-0.44	-12.06	-143.69
Cash EPS ($)	--	-5.07	-224.92	-0.44	-12.03	-143.55
Adjusted Book Value ($)	--	1.20	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.03	-116.89	-0.18	-6.52	-81.22
Free Cash Flow per Share ($)	--	-0.03	-116.89	-0.18	-6.52	-81.22

Profitability Ratios	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
ROCE (%)	--	-920.51	67.42	116.85	121.63	89.52
ROE (%)	-151.81	-1,163.67	52.81	86.67	87.27	60.40
ROA (%)	-82.19	-598.08	-2,744.68	-3,748.44	-5,610.44	-3,630.21
EBIT Margin (%)	-59,201.15	--	--	--	--	--
Net Margin (%)	-61,399.58	--	--	--	--	--
Cash Profit Margin (%)	-2.85	--	--	--	--	--

Growth Ratios	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	67.70	-4,446.35	43.15	-5.46	-26.69	45.96
Net Profit Growth (%)	66.74	-3,135.77	31.57	-0.11	-31.19	57.27
EPS Growth (%)	89.18	0.98	-514.90	0.96	0.92	1.00
Book Value Growth (%)	161.95	--	--	--	--	--

Valuation Ratios	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Price / Earnings	0.00	-0.82	-0.16	-9,179.09	-9,141.88	-6,959.53
Price / Book Value	0.15	3.47	-0.08	-7,835.79	-8,036.35	-4,596.47
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	2.90	-0.86	-0.97	-10,928.90	-11,360.52	-8,353.48
Close Price ($)	2.65	103.75	937.50	101,250.00	2,756,250.75	25,000,000.00
High Price ($)	275.00	3,636.50	196,875.00	5,287,506.00	25,000,000.00	25,000,000.00
Low Price ($)	2.56	31.25	450.00	15,000.00	1,350,001.50	975,000.75
Market Cap ($ Cr)	1.39	--	--	--	--	--

Solvency Ratios	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Debt to Equity	--	0.12	-0.25	-0.18	-0.34	-0.22
Short term debt to equity ratio	0.06	0.11	-0.24	-0.17	-0.33	-0.22
Current Ratio	2.37	1.50	0.01	0.01	0.00	0.00
Quick Ratio	2.37	--	--	0.01	--	0.00
Interest Coverage	-26.93	-103.52	-1.93	-4.24	-3.76	-3.76

Operating Efficiency Ratios	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Debtors to sales (%)	36.97	--	--	--	--	--
Asset Turnover	0.00	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	-48.35	-58.96	-279.59	-28.21
Payable days	--	--	18,384.38	19,637.75	62,646.98	11,982.43
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.